NASDAQ: HTFL

Heartflow (HTFL) Stock Analysis & Forecast

Nov 13 close

$48.46−11.46 (−19.1%)

Gekko Brief

AI summaryNov 9 close

Heartflow's week centers on clinical data presented at major cardiology conferences, alongside a shifting analyst picture ahead of earnings. At TCT 2026, the company presented 12-month data showing its CT-guided PCI planning is non-inferior to intravascular ultrasound, with a 17-minute reduction in procedure time and a 12% decrease in contrast volume. Separately, data from the DECIDE registry, presented at AHA 2026, associated Heartflow's AI-powered plaque analysis with 34% fewer major cardiovascular events and half the rate of heart attack at one year versus CCTA alone. Wall Street Zen lowered its stock rating on HTFL, and options data point to a possible 17% move around the 12 November earnings report.

HTFL closes at $56.66, up 8.1%, sitting above both its 50-day ($51.46) and 200-day ($34.72) averages, with the shorter average above the longer one. The GekkoIndex reads 53.9, placing the stock in the Neutral zone, up 2.4 over five days. Price sits 11.2% above Gekko Fair Value of $50.97.

The next 20 trading days bring the earnings report on 12 November, just 2 days out, following a prior quarter where actual EPS of -1.46 missed estimates of -0.22 and the stock reacted with a 41% move; average absolute reaction across recent quarters runs 18.7%. Options data flag a potential 17% move around the report. No insider, Congress, or unusual options activity appears in their respective windows, though one billionaire holder and two trailblazer holders are recorded. Analyst consensus among 8 firms stands at 6 buy and 2 hold, with a consensus target of $50.50.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Heartflow price vs fair value

$51.95$48.46Nov ’25May ’26Nov ’26
Close $48.46200-day averageGekko Fair Value $51.95

Heartflow quick facts

Market cap
$4.21B
P/E ratio
—
Forward P/E
—
EPS, TTM
−$0.24
Revenue, TTM
$238.7M
Profit margin
-33.1%
Dividend yield
—
Beta
—
Volume
3.70M avg 1.84M
1-year return
+35.6%
Typical daily move
±8.8%
Typical 20-day move
±11.8%
50-day average
$51.91
200-day average
$35.21
Next earnings
—
Shares outstanding
86.95M
52-week range
$20.13$60.66

Heartflow swing-trade checklist

Heartflow scores 2 supportive, 1 mixed and 0 headwinds across the 3 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive1 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $48.46 sits between the 50-day ($51.91) and 200-day ($35.21) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    60.9, Accumulation

    Reading 60.9 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    6.7% below

    Price is 6.7% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings riskno data

    No data

    No confirmed report date on the calendar.

    See earnings
  • Seasonalityno data

    No data

    Not enough years of history for a seasonal read.

A description of current data, not a recommendation. How this page works

Heartflow stock chart and price history

Heartflow closed at $48.46 on Nov 13, 2026, +35.6% over the past year, inside a 52-week range of $20.13 to $60.66.

Close50-day average200-day averageVolume
Heartflow share price, past year, with 50-day and 200-day moving averages and volume$20$30$40$60DecJan 2026FebMarAprMayJunJulAugSepOctNov48.46

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−4.8%
3 months
+15.5%
6 months
+71.1%
1 year
+35.6%
The full HTFL chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HTFL in Gekko

Follow Heartflow through every session

Put HTFL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track HTFL in GekkoFree for 7 days. No credit card required.

About Heartflow

Heartflow makes technology used to diagnose and manage coronary artery disease without surgery. Its core offering, the Heartflow Platform, uses artificial intelligence and computational fluid dynamics to build a three-dimensional digital model of a patient's heart from a single coronary CT angiography scan. The platform is best known for turning that one scan into detailed readings of blood flow, arterial narrowing, and plaque volume and makeup, addressing gaps left by conventional non-invasive imaging.

The company positions its platform as a tool for clinicians involved in heart disease diagnosis and ongoing patient care, built around the CCTA scan as its data source rather than requiring additional invasive procedures.

Heartflow was founded in 2007 and is headquartered in Mountain View, California. Its shares are listed on the NASDAQ under the ticker HTFL.

Listed
NASDAQ
Sector
Technology services
Industry
Packaged software
Website
heartflow.com

Heartflow GekkoIndex: the smart money zone

Heartflow’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.9, in the Accumulation zone, up 3.2 points over five sessions.

010060.9Accumulation

Up 3.2 points over five sessions, from the Neutral zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying9Too few readings yet
Accumulation (current zone)89−0.3%+1.4%+16.3%+26.7%
Neutral183+2.8%+4.9%+3.1%+5.0%
Distribution22−6.2%−6.1%−6.0%+8.8%
Selling7Too few readings yet

Average HTFL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the HTFL price, zone by zone.Track HTFL in Gekko

Is Heartflow stock overvalued? Gekko Fair Value

Heartflow trades 6.7% below Gekko Fair Value of $51.95, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Heartflow shares are worth, recalculated every trading day.

$51.95

Gekko Fair Value, Nov 14, 2026

6.7% Undervalued

At the end of Aug 2026 the price was 26.9% above the estimate.

Gekko Fair ValueShare price, month end
$52$48Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open HTFL in Gekko

Heartflow insider and Congress trading

No open-market insider purchases were filed for Heartflow, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for HTFL in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every HTFL insider filing, plotted on the chart in Gekko.Open HTFL in Gekko

Congress trades last 90 days

No trades in HTFL were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for HTFL, plotted on the chart in Gekko.Open HTFL in Gekko

Buybacks

Heartflow has been buying back its own shares.

Bought back, quarter ended Mar 31, 2026
$3.29M
As a share of market cap
0.08%

From company filings.

Hedge funds and billionaires quarter ended Sep 30

2of the funds Gekko tracks hold HTFL.

1added1opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

Heartflow earnings: next date and track record

Heartflow beat the EPS estimate in 2 of its last 5 reports, moving 18.7% on average across the report.

2 of 5reports beat the EPS estimate
±18.7%average move across the report
2 of 4reports followed by a gain

Share-price move across each report

−9.5%Nov ’25+15.0%Mar ’26−9.2%May ’26+41.0%Aug ’26

Last earnings call, Aug 13, 2026 AI summary

What they said
HeartFlow reported Q2 2026 revenue of $64.1 million, up 48% year-over-year (51% U.S.), marking the fastest growth in 8 quarters. Growth was driven by Plaque product acceleration, durable FFRCT utilization, strong new account additions, and expanding CCTA market. Non-GAAP gross margin guidance raised to ~82%, implying ~50% gross profit growth year-over-year at midpoint.
Guidance
Full-year 2026 revenue guidance raised to $246-$250 million (40-42% growth). Plaque revenue outlook raised to $29-$31 million with ~1,250 Plaque-activated accounts targeted. Mid-term non-GAAP gross margin target remains 85%.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 13, 2026−$1.46
est −$0.22
−563.6%$64.08M
est $56.64M
+13.1%+41.0%
May 14, 2026−$0.16
est −$0.17
+5.9%$52.59M
est $49.71M
+5.8%−9.2%
Mar 18, 2026−$0.12
est −$0.15
+21.2%$49.13M
est $46.58M
+5.5%+15.0%
Nov 12, 2025−$0.27
est −$0.20
−35.0%$46.28M
est $46.30M
−0.1%−9.5%
Jul 17, 2025−$0.46
est −$0.21
−116.0%$37.20M
est $43.20M
−13.9%—

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Heartflow stock forecast and analyst price targets

Analysts’ average 12-month price target for Heartflow is $52.00, +7.3% from the last close, from 8 firms rating the stock in the last 90 days.

$52.00consensus 12-month target, +7.3% from the last close
Low $40High $70
Buy6
Hold2
Sell0

Each firm’s latest rating in the last 90 days: 8 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 13Wells FargoBuy, reiterated$70+44.4%
Nov 13Stifel NicolausBuy, maintained$70+44.4%
Nov 13Robert W. BairdBuy, maintained$68+40.3%
Nov 13Piper SandlerBuy, reiterated$64+32.1%
Nov 13Canaccord GenuityBuy, reiterated$69+42.4%
+16.3%average 20-day move after past Accumulation readings
±8.8%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Heartflow market cap and key statistics

Heartflow’s market cap is $4.21B and revenue of $238.7M over the last twelve months.

Valuation

Market cap
$4.21B
EPS, TTM
−$0.24
Gekko Fair Value
$51.95

Trading

Volume
3.70M
Avg volume, 20 days
1.84M
52-week high
$60.66
52-week low
$20.13
Shares outstanding
86.95M

Financials

Revenue, TTM
$238.7M
Profit margin
-33.1%
Return on equity
-29.4%
Quarterly earnings growth, YoY
0.0%

Risk and income

Typical daily move
±8.8%
Typical 20-day move
±11.8%

Heartflow peers

Heartflow’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
MSFTMicrosoft+0.8%Neutral10.6% above
PLTRPalantir Technologies−2.2%Accumulation8.2% below
ORCLOracle−1.7%Neutral27.9% below
PANWPalo Alto Networks−2.5%Accumulation0.6% above
CRWDCrowdStrike−4.0%Accumulation0.9% above
CRMSalesforce−1.0%Accumulation12.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Packaged software

Heartflow stock FAQ

What is Heartflow’s market cap?

Heartflow’s market cap is $4.21B at the Nov 13, 2026 close of $48.46, with 86.95M shares outstanding.

What is the Heartflow stock forecast?

The consensus analyst 12-month price target for Heartflow is $52.00, +7.3% from the last close. Of the 8 firms that rated the stock in the last 90 days, 6 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Heartflow stock overvalued or undervalued?

On Gekko’s estimate Heartflow is undervalued: the Nov 13, 2026 close of $48.46 is 6.7% below Gekko Fair Value of $51.95. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

What is Heartflow’s 52-week high and low?

Heartflow’s 52-week high is $60.66 and its 52-week low is $20.13; it closed at $48.46 on Nov 13, 2026, +35.6% over the past year.

Is Heartflow stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 3 items with data read as supportive (gekkoindex and fair value), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Heartflow the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.